Skip to main content
Premium Trial:

Request an Annual Quote

XPhyto, TechUnit Sign Agreement to Distribute COVID-19 Test in Czech Republic

NEW YORK – XPhyto Therapeutics said on Thursday that it has signed a distribution agreement with TechUnit to distribute XPhyto's COVID-ID Lab test in the Czech Republic. 

Under the agreement, TechUnit has the right to distribute and sub-distribute the test on a nonexclusive basis, with the potential for territorial exclusivity based on performance. XPhyto said in a statement that the companies are "reviewing opportunities" for distribution of the test in additional territories, including Hungary, Slovakia, Ukraine, and Russia.

Vancouver, British Columbia-based XPhyto also said it will provide TechUnit with technical training and product, strategy, and marketing support.

Financial and other terms of the deal were not disclosed.

The RT-PCR test doesn't require RNA extraction, needing only a 20-minute PCR run. Once the sample is processed, it's placed on a chip, which can detect the virus in five minutes, the company said. The test, which was developed with German diagnostics firm 3a-diagnostics, received CE marking in March. XPhyto acquired 3a-diagnostics for $4.6 million in July of last year.

The Scan

Time to Act

A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.

Fulgent Seeking Defamation Suit

Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports.

Speeding Gene-Edited Crops

Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.

Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability

In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.